EMJ Podcast: Insights For Healthcare Professionals

This week’s episode focuses on innovations in diabetes technology, such as flash glucose monitoring and hybrid closed loop systems. Jonathan and Partha Kar, National Specialty Advisor in Diabetes for the National Health Service (NHS), UK, discuss promising innovations on the horizon, such as immunotherapy, as well as the importance of exercising caution on social media, and Partha’s Type 1 diabetes comic book.

Use the following timestamps to navigate the content in this episode: 

(00:00)-Introduction

(02:40)-Partha’s love of comic books

(04:30)-Why diabetes?

(06:09)-Promoting technology in Type 1 Diabetes 

(08:25)-Patient responsibility

(10:05)-Labelling patients with diabetes

(11:28)-Hybrid closed loop systems

(14:40)-Impact on the NHS and global healthcare

(16:04)-Pioneering the diabetes ‘super six’ model

(18:02)-Social media and combatting pseudoscience

(21:15)-Considering racism

(24:06)-Diabetes on ‘the big screen’

(27:31)-Game changing drugs for diabetes

(29:40)-Innovation: stem cells and immunotherapy

(31:24)-Partha’s three wishes for healthcare

(32:40)-Concluding remarks

Jonathan is joined by Geraldine Dawson, Director of the Duke Center for Autism and Brain Development, USA. In the second of a two-part episode, the pair discuss face processing in young children with autism, the use of datasets in autism research, and biomarkers for potential treatment.

 

Use the following timestamps to navigate the content in this episode: 

 

(00:00)-Introduction

(00:42)-Digital behaviour phenotyping for the early detection of autism

(07:11)-Research on early autism detection models based on electronic health records

(12:43)-The application of artificial intelligence and computer vision in early autism detection

(15:11)-Brain circuitry, and the techniques and implications of electrophysiological techniques

(20:16)-Three wishes for the future of healthcare

In this podcast, Dr. Chryssoula Tzialla, a paediatrician and Director of the Paediatrics and Neonatalology unit at Voghera Azienda Socia-Sanitaria Territoriale of Pavia in Italy, discusses the impact of respiratory syncytial virus (RSV), the seasonal patterns of RSV, and the importance of prevention strategies, such as non-pharmacological approaches.   This podcast was organised and funded by Sanofi. The statements are reflecting the opinion of the expert interviewed based on their clinical experience   MAT-GLB-2306088

In this week’s episode, Jonathan is joined by Geraldine Dawson, Director of the Duke Center for Autism and Brain Development, and the Duke Autism Clinic, Durham, North Carolina, USA. In the first of a two-part episode, the pair discuss autism screening, the characteristics of autism in infancy, and the benefits of early intervention in social interactions.

Use the following timestamps to navigate the content in this episode:  (00:00)-Introduction (02:15)-What led Dawson to an academic career in psychology and autism (05:09)-How do we characterise being ‘on the spectrum’? (09:29)-Aetiology of autism: genetic and environmental factors (13:20)-Dawson’s early, groundbreaking research into autism symptoms in infancy (17:17)-Why is the incidence of autism increasing? (19:45)-The Early Start Denver Model: early autism interventions (23:24)-Time Magazine’s medical breakthrough of 2012

This week, James Hull, Consultant Respiratory Physician, Royal Brompton Hospital, London, UK, takes Jonathan on a deep dive into respiratory care, from combatting breathlessness to airway collapse in athletes. The pair also discuss the common misconceptions surrounding asthma diagnosis, recent technological advancements, and the potential challenges behind emerging treatments.

Use the following timestamps to navigate the content in this episode:

(00:00)-Introduction

(2:17)-What got Hull into medicine?

(03:34)-Relationship between exercise and breathlessness

(06:22)-Anxiety and breathlessness

(10:24)-Optimising respiratory health in elite athletes

(13:52)-RELACS; managing large airway collapse

(16:10)-New methods for diagnosing upper airway problems

(20:09)-New developments in treating asthma

(23:10)-Challenges in respiratory medicine

(25:04)-Respiratory medicine and sports committees

(26:38)-Three wishes for the future of healthcare 

The information contained in this podcast is intended for a European healthcare professional audience for continuing education purposes only. This podcast was supported by Jazz Pharmaceuticals, which  had input into the concept and topic, but not the content of the podcast. The views expressed in this podcast are those of the individual speakers and do not necessarily reflect the views of Jazz Pharmaceuticals.

Lennox–Gastaut syndrome (LGS) is a rare, severe, and progressive childhood-onset epilepsy characterised by recurrent seizures. LGS can be challenging to diagnose due to multiple aetiologies, varying clinical presentation at onset, and a lack of specific biological markers. These challenges can be compounded in adulthood due to the evolving presentation of LGS over time, and incomplete medical histories. In this insightful podcast, experts Steve Chung, University of Arizona, Phoenix, USA; and Rhys Thomas, Royal Victoria Infirmary, Newcastle, UK, explore the identification, diagnosis, and management of LGS in both children and adults based on their experiences in real-life clinical settings.

In this week’s episode, Jonathan is joined by Aleksander Lühr Hansen, Steno Diabetes Center, Copenhagen, Denmark; and Aarhus University Hospital, Denmark. The pair discuss low birthweight and fetal programming, in the context of the associated increased risk of developing conditions like Type 2 diabetes.  

Use the following timestamps to navigate the content in this episode:

(00:00)-Introduction 

(01:50)-Alexander’s route in medicine and diabetes 

(03:50)-Research on low birthweight 

(05:44)-Fetal programming 

(10:11)-The ‘thrifty phenotype’ 

(12:55)-Low birthweight and Type 2 diabetes development 

(19:45)-Alexander’s experiences in Tanzania 

(24.06)-Adverse pregnancy outcomes and incident heart failure 

(27.19)-The translational Type 2 diabetes research group 

(30:00)-Projects for the future 

(33.01)-Three wishes 

Jonathan is joined by Simon Fleming, orthopaedic surgeon, Royal North Shore Hospital, Sydney, Australia, and Fellow of the Royal College of Surgeons of England. Passionate about improving the quality and culture of healthcare, Simon discusses advocating for increased education standards, and his groundbreaking work to drive out bullying, discrimination, and harassment in healthcare.  

Use the following timestamps to navigate the content in this episode:  

(00:00)-Introduction 

(02:12)-Fleming the orthopod  

(08:05)-Training and practicing in Britain and Australia 

(13:40)-Similarities and dissimilarities 

(15:56)-Rocking the boat  

(21:28)-Bullying and discriminatory behaviours in healthcare 

(23:11)-The BOTA census 

(26:09)-TEDx NHS 

(29:14)-Holding sexual predators accountable  

(34:00)-Pronouns 

(37:35)-#OrthoTwitter  

(40:35)-Flawed assessment in healthcare 

(43:46)-Influencing the next generation 

(46:36)-Three wishes for the future of healthcare 

The publication of this podcast was funded by CSL Behring. The views and opinions expressed are exclusively those of the speakers.

In this section, the panel considers the diagnostic tools and approaches available for healthcare professionals to use for suspected idiopathic pulmonary fibrosis (IPF). The discussion is directed towards the expertise of Prof. Luca Richeldi, who emphasises the importance of knowledge, education, and medical examination approaches for addressing the unmet medical needs associated with the awareness of, and diagnostic delays of IPF.

The publication of this podcast was funded by CSL Behring. The views and opinions expressed are exclusively those of the speakers.

In this section, which is directed towards the expertise of Prof. McElvaney, the discussion focuses specifically on the relevance of detecting and diagnosing Alpha 1 Antitrypsin Deficiency (AATD) for lung diseases, as well as consideration of other diagnostic techniques and standards of care options for patients with AATD.